Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China
Yutao Guo(Chinese General Hospital College of Nursing and Liberal Arts), Gregory Y.H. Lip(Medical University of Białystok), Yingchun Tian(Second People's Hospital of Yunnan Province), Yutang Wang(Federation University), Hao Wang(Cangzhou Central Hospital), Quanjin Si(Chinese PLA General Hospital)
Cited by 270
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919